Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population.
Diagnostic yield of pediatric and prenatal exome sequencing in a diverse population.
复制标题
小儿和产前外显子组测序的诊断产量在多样化的人群中。
DOI:
10.1038/s41525-023-00353-0
复制
发表时间:
2023-05-26
影响因子:
5.3
通讯作者:
Norton, Mary E.
中科院分区:
文献类型:
--
作者:
Slavotinek, Anne;Rego, Shannon;Sahin-Hodoglugil, Nuriye;Kvale, Mark;Lianoglou, Billie;Yip, Tiffany;Hoban, Hannah;Outram, Simon;Anguiano, Beatrice;Chen, Flavia;Michelson, Jeremy;Cilio, Roberta M.;Curry, Cynthia;Gallagher, Renata C.;Gardner, Marisa;Kuperman, Rachel;Mendelsohn, Bryce;Sherr, Elliott;Shieh, Joseph;Strober, Jonathan;Tam, Allison;Tenney, Jessica;Weiss, William;Whittle, Amy;Chin, Garrett;Faubel, Amanda;Prasad, Hannah;Mavura, Yusuph;Van Ziffle, Jessica;Devine, W. Patrick;Hodoglugil, Ugur;Martin, Pierre-Marie;Sparks, Teresa N.;Koenig, Barbara;Ackerman, Sara;Risch, Neil;Kwok, Pui-Yan;Norton, Mary E.
The diagnostic yield of exome sequencing (ES) has primarily been evaluated in individuals of European ancestry, with less focus on underrepresented minority (URM) and underserved (US) patients. We evaluated the diagnostic yield of ES in a cohort of predominantly US and URM pediatric and prenatal patients suspected to have a genetic disorder. Eligible pediatric patients had multiple congenital anomalies and/or neurocognitive disabilities and prenatal patients had one or more structural anomalies, disorders of fetal growth, or fetal effusions. URM and US patients were prioritized for enrollment and underwent ES at a single academic center. We identified definitive positive or probable positive results in 201/845 (23.8%) patients, with a significantly higher diagnostic rate in pediatric (26.7%) compared to prenatal patients (19.0%) (P = 0.01). For both pediatric and prenatal patients, the diagnostic yield and frequency of inconclusive findings did not differ significantly between URM and non-URM patients or between patients with US status and those without US status. Our results demonstrate a similar diagnostic yield of ES between prenatal and pediatric URM/US patients and non-URM/US patients for positive and inconclusive results. These data support the use of ES to identify clinically relevant variants in patients from diverse populations.
登录
查看更多内容
影响因子:
4.6
作者:
Pode-Shakked B;Barel O;Singer A;Regev M;Poran H;Eliyahu A;Finezilber Y;Segev M;Berkenstadt M;Yonath H;Reznik-Wolf H;Gazit Y;Chorin O;Heimer G;Gabis LV;Tzadok M;Nissenkorn A;Bar-Yosef O;Zohar-Dayan E;Ben-Zeev B;Mor N;Kol N;Nayshool O;Shimshoviz N;Bar-Joseph I;Marek-Yagel D;Javasky E;Einy R;Gal M;Grinshpun-Cohen J;Shohat M;Dominissini D;Raas-Rothschild A;Rechavi G;Pras E;Greenbaum L
通讯作者:
Greenbaum L
DOI:
10.1097/gim.0b013e3181f8baad
发表时间:
2010-11
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
Manning M;Hudgins L;Professional Practice and Guidelines Committee
通讯作者:
Professional Practice and Guidelines Committee
影响因子:
3.2
作者:
Jooma, Sonya;Hahn, Michael J.;Bonham, Vence L.
通讯作者:
Bonham, Vence L.
影响因子:
12.3
作者:
Kingsmore, Stephen F.;Lantos, John D.;Saunders, Carol J.
通讯作者:
Saunders, Carol J.
影响因子:
168.9
作者:
Petrovski, Slave;Aggarwal, Vimla;Wapner, Ronald J.
通讯作者:
Wapner, Ronald J.